Table of contents

Cardiovascular medicine

• Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990–2000: population-based cohort study (14 June, 2006)

  S Capewell, N F Murphy, K MacIntyre, S Frame, S Stewart, J W T Chalmers, J Boyd, A Finlayson, A Redpath, J J V McMurray
• Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry (27 April, 2006)

  M Heras, H Bueno, A Bardají, A Fernández-Ortiz, H Martí, J Marrugat
• Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial (1 June, 2006)

  M Sejersten, Y Birnbaum, R S Ripa, C Maynard, G S Wagner, P Clemmensen
• Retinal vascular calibre and the risk of coronary heart disease-related death (13 July, 2006)

  J J Wang, G Liew, T Y Wong, W Smith, R Klein, S R Leeder, P Mitchell
• Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies (1 June, 2006)

  G A Whalley, G D Gamble, R N Doughty
• Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups (8 June, 2006)

  P Brindle, M May, P Gill, F Cappuccio, R D’Agostino, C Fischbacher, S Ebrahim
• Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure (18 May, 2006) Free

  C H Strey, J M Young, J H Lainchbury, C M Frampton, M G Nicholls, A M Richards, R S Scott
• Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population (22 May, 2006)

  C Huerta, C Varas-Lorenzo, J Castellsague, L A García Rodríguez
• Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction (18 May, 2006)

  T Weber, J Auer, M F O’Rourke, C Punzengruber, E Kvas, B Eber
• Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation (1 June, 2006)

  T Date, T Yamane, K Inada, S Matsuo, S Miyanaga, K Sugimoto, K Shibayama, I Taniguchi, S Mochizuki
• Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay (18 May, 2006)

  Z I Whinnett, J E R Davies, K Willson, C H Manisty, A W Chow, R A Foale, D Wyn Davies, A D Hughes, J Mayet, D P Francis
• Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin (18 May, 2006)

  S A Harding, J N Din, J Sarma, D H Josephs, K A A Fox, D E Newby
• Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis (1 June, 2006)

  M Weber, M Hausen, R Arnold, H Nef, H Moellman, A Berkowitsch, A Elsaesser, R Brandt, V Mitrovic, C Hamm
• Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients (18 May, 2006)

  J Dernellis, M Panaretou
• Predictors of patients’ preferences for treatments to prevent heart disease (18 May, 2006)

  T Marshall, S Bryan, P Gill, S Greenfield, K Gutridge
• Rapid screening for major depression in post-myocardial infarction patients: an investigation using Beck Depression Inventory II items (27 April, 2006)

  J C Huffman, F A Smith, M A Blais, M E Beiser, J L Januzzi, G L Fricchione